Gene · 27329
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The evaluation of plozasiran for the treatment of familial chylomicronemia syndrome. | Expert Rev Endocrinol Metab | 2026 | 41860018 | PubTator, text mining | PubMed |
| ANGPTL3 Gene Editing: Promise and Prudence. | Eur Cardiol | 2026 | 41858947 | PubTator, text mining | PubMed |
| Post-heparin plasma lipase activities in patients with severe hypertriglyceridemia treated with evinacumab. | J Lipid Res | 2026 | 41831525 | PubTator, text mining | PubMed |
| Genetic Variation in the Chemokine Network and Atherosclerosis Risk. | Curr Atheroscler Rep | 2026 | 41824188 | PubTator, text mining | PubMed |
| Clinical Determinants and Prognostic Significance of Circulating Angiopoietin-Like Protein 3 Levels in Patients With Chronic Coronary Syndrome. | Circ Rep | 2026 | 41808948 | PubTator, text mining | PubMed |
| ANGPTL3-lowering strategies to address residual cardiovascular risk. | Nat Rev Cardiol | 2026 | 41807757 | PubTator, text mining | PubMed |
| A Narrative Review of Remnant Cholesterol as an Independent Atherogenic Lipoprotein in Type 2 Diabetes: Pathophysiology and Clinical Implications. | Ther Clin Risk Manag | 2026 | 41799835 | PubTator, text mining | PubMed |
| Biochemical characterisation of familial hypercholesterolemia: Associations between genetic and lipid profiles. | J Med Biochem | 2026 | 41799714 | PubTator, text mining | PubMed |
| SiRNA-based inactivation of Angptl3 alleviates high-fat diet-induced MAFLD and atherosclerosis in LDLR-deficient hamsters. | Lipids Health Dis | 2026 | 41787476 | PubTator, text mining | PubMed |
| Disruption of the angiopoietin-like system connects lipid homeostasis and hypothalamic dysfunction in ALS. | BMC Med | 2026 | 41776545 | PubTator, text mining | PubMed |
| A narrative review of impacts of apolipoproteins on atherosclerotic coronary plaques. | NPJ Cardiovasc Health | 2026 | 41775966 | PubTator, text mining | PubMed |
| CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia. | Signal Transduct Target Ther | 2026 | 41775694 | PubTator, text mining | PubMed |
| Effects of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors on Lipid Profiles in Type 2 Diabetes: A Systematic Review. | Cureus | 2026 | 41773139 | PubTator, text mining | PubMed |
| Methods for Prioritizing Causal Genes in Molecular Studies of Human Disease: The State of the Art. | Genet Epidemiol | 2026 | 41770856 | PubTator, text mining | PubMed |
| Representation is Prevention: Closing the Sex Gap in Novel Cardiovascular Clinical Trials. | Am J Prev Cardiol | 2026 | 41767457 | PubTator, text mining | PubMed |
| Baseline characteristics and response to evinacumab in females and males with homozygous familial hypercholesterolemia in the ELIPSE OLE study. | Am J Prev Cardiol | 2026 | 41767444 | PubTator, text mining | PubMed |
| Crosstalk between SPP1+ macrophages and ITGA5+ fibroblasts promotes hepatocellular carcinoma metastasis. | Hepatol Commun | 2026 | 41758046 | PubTator, text mining | PubMed |
| Alteplase and Angioedema: Can Clinical Exome Sequencing Redefine the Paradigm? | Life (Basel) | 2026 | 41752838 | PubTator, text mining | PubMed |
| Choosing the Right Non-Statin Therapy for the Right Patient - How To Sequence Advanced Lipid-Lowering Therapies. | Curr Atheroscler Rep | 2026 | 41746457 | PubTator, text mining | PubMed |
| Atherogenic Dyslipidemia in Children and Adolescents: Current Evidence, Clinical Challenges, and Future Perspectives. | J Cardiovasc Dev Dis | 2026 | 41745337 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27329/papers?page=5